Abstract
Lynch syndrome (LS) is an inherited form of colorectal cancer (CRC) caused by germline mutations in the mismatch repair (MMR) genes. It accounts for approximately 5 % of all CRCs. The prevalence of LS among US Hispanics is unknown. The objective of this study was to describe the germline mutations of LS in Caribbean Hispanics from Puerto Rico and Dominican Republic. A total of 89 subjects were recruited through the Puerto Rico Familial Colorectal Cancer Registry and were classified according to Amsterdam and Bethesda clinical guidelines. For those tumors with lack of expression of MMR protein, gene sequencing was ordered. A total of 35 individuals with deficient MMR system were identified: 22 had MMR mutations and 13 had tumors with absent MMR protein expression. Our results show that the mutation spectrum of Caribbean Hispanic LS patients was composed mostly of MSH2 (66.7 %) mutations, followed by MLH1 (25.0 %). One mutation was identified in MSH6 (8.3 %). A previously unidentified mutation in MLH1 gene c.2044_2045del was found in one Caribbean Hispanic family. MMR mutation-positive individuals were found to be more likely to have a prominent family history of CRC and tumors located at the proximal colon. Compared to MSH2 mutation carriers, MLH1 mutation-positive individuals were more likely to have a strong family history of CRC and LS associated cancers. Furthermore, insurance coverage for genetic testing was found to be limited in the study population with 65.1 % of the individuals recruited were denied coverage. This report presents the first description of the mutation spectrum and clinicopathologic characteristics of LS Caribbean Hispanics patients.
Similar content being viewed by others
References
Varela A, Jandorf L, Duhamel K (2010) Understanding factors related to colorectal cancer (CRC) screening among urban Hispanics: use of focus group methodology. J Cancer Educ 25(1):70–75. doi:10.1007/s13187-009-0015-z
Soto-Salgado M, Suarez E, Calo WA, Cruz-Correa M, Figueroa-Valles N, Ortiz AP (2009) Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United Staes, 1998–2002. Cancer 115(13):3016–3023
Tortolero-Luna G, Zavala-Zegarra D, Perez-Rios N, Torres-Cintron CR, Ortiz-Ortiz KJ, Traverso-Ortiz M, Roman-Ruiz Y, Veguilla-Rosario I, Vazquez-Cubano N, Merced-Velez MF, Ojeda-Reyes G, Hayes-Velez FJ, Ramos-Cordero M, Lopez-Rodriguez A, Perez-Rosa N (2013) Cancer in Puerto Rico, 2006–2013. Puerto Rico Central Cancer Registry, p 22. https://drive.google.com/file/d/0B98Xadlvfjz4REQtbGxLTUt5UTQ/edit
Hegde M, Ferber M, Mao R, Samowitz W, Ganguly A (2014) ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis). Genet Med 16(1):101–116. doi:10.1038/gim.2013.166
Jasperson KW, Tuohy TM, Neklason DW, Burt RW (2010) Hereditary and familial colon cancer. Gastroenterology 138(6):2044–2058. doi:10.1053/j.gastro.2010.01.054
Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ (1995) Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64(6):430–433
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A (2008) Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol 26(35):5783–5788. doi:10.1200/JCO.2008.17.5950
Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860. doi:10.1056/NEJMoa043146
Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, de la Chapelle A (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129(2):415–421. doi:10.1016/j.gastro.2005.05.011
Lindor NM, Petersen GM, Hadley DW, Kinney AY, Miesfeldt S, Lu KH, Lynch P, Burke W, Press N (2006) Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome: a systematic review. JAMA 296(12):1507–1517. doi:10.1001/jama.296.12.1507
Vasen HF, Blanco I, Aktan-Collan K (2013) Revised guidelines for the clinical management of lynch syndrome (HNPCC): recommendations by a group of European experts. Gut 62(6):812–823
Pritchard CC, Grady WM (2011) Colorectal cancer molecular biology moves into clinical practice. Gut 60(1):116–129. doi:10.1136/gut.2009.206250
Pena-Diaz J, Jiricny J (2012) Mammalian mismatch repair: Error-free or error-prone? Trends Biochem Sci 37(5):206–214. doi:10.1016/j.tibs.2012.03.001
Medina-Arana V, Delgado L, Bravo A, Martín J, Fernández-Peralta AM, González-Aguilera JJ (2012) Tumor spectrum in Lynch syndrome, DNA mismatch repair system and endogenous carcinogens. J Surg Oncol 106(1):10–16. doi:10.1002/jso.23054
Avena S, Via M, Ziv E, Perez-Stable EJ, Gignoux CR, Dejean C, Huntsman S, Torres-Mejia G, Dutil J, Matta JL, Beckman K, Burchard EG, Parolin ML, Goicoechea A, Acreche N, Boquet M, Rios Part Mdel C, Fernandez V, Rey J, Stern MC, Carnese RF, Fejerman L (2012) Heterogeneity in genetic admixture across different regions of Argentina. PLoS One 7(4):e34695. doi:10.1371/journal.pone.0034695
Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456
Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268
Pino MS, Mino-Kenudson M, Wildemore BM, Ganguly A, Batten J, Sperduti I, Iafrate AJ, Chung DC (2009) Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn 11(3):238–247. doi:10.2353/jmoldx.2009.080142
Marques-Lespier JM, Diaz-Algorri Y, Gonzalez-Pons M, Cruz-Correa M (2014) Report of a novel mutation in MLH1 gene in a Hispanic family from Puerto Rico fulfilling classic Amsterdam criteria for Lynch syndrome. Gastroenterol Res Pract 2014:527946. doi:10.1155/2014/527946
Tomita N, Fukunaga M, Ohzato H, Tamura S, Sugimoto K, Aihara T, Miki H, Takatsuka Y, Matsuura N, Iwanaga T, Fukayama N, Sugano K (2003) The novel germline mutation of hMSH2 gene in a case of a hereditary non-polyposis colorectal cancer (HNPCC) patient who meets the revised Amsterdam criteria. Jpn J Clin Oncol 33(9):486–489
Stella A, Surdo NC, Lastella P, Barana D, Oliani C, Tibiletti MG, Viel A, Natale C, Piepoli A, Marra G, Guanti G (2007) Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC. Clin Genet 71(2):130–139. doi:10.1111/j.1399-0004.2007.00745.x
South CD, Hampel H, Comeras I, Westman J, Frankel WL, de La Chapelle A (2008) The frequency of Muir-Torre syndrome among Lynch syndrome families. J Natl Cancer Inst 100(4):277–281
De Jesus-Monge WE, Gonzalez-Keelan C, Zhao R, Hamilton SR, Rodriguez-Bigas M, Cruz-Correa M (2010) Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer 9(2):155–166. doi:10.1007/s10689-009-9310-4
Lynch H, de La Chapelle A (1999) Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801–818
Alvarez K, Hurtado C, Hevia MA, Wiedlandt AM, de la Fuente M, Church J, Carvallo P, Lopez-Kostner F (2010) Spectrum of MLH1 and MSH2 mutations in Chilean families with suspect Lynch syndrome. Dis Colon Rectum 53:450–459
Dominguez-Valentin M, Nilbert M, Wernhoff P, Lopez-Kostner F, Vaccaro C, Sarroca C, Palmero EI, Giraldo A, Ashton-Prolla P, Alvarez K, Ferro A, Neffa F, Caris J, Carraro DM, Rossi BM (2013) Mutation spectrum in South American Lynch syndrome families. Hered Cancer Clin Pract 11(1):18. doi:10.1186/1897-4287-11-18
Thiffault I, Foulkes WD, Marcus VA, Farber D, Kasprzak L, MacNamara E, Wong N, Hutter P, Radice P, Bertario L, Chong G (2004) Putative common origin of two MLH1 mutations in Italian-Quebec hereditary non-polyposis colorectal cancer families. Clin Genet 66:137–143
Valentin MD, da Silva FC, dos Santos EM, Lisboa BG, de Oliveira LP, Ferreira Fde O, Gomy I, Nakagawa WT, Aguiar Junior S, Redal M, Vaccaro C, Valle AD, Sarroca C, Carraro DM, Rossi BM (2011) Characterization of germline mutations of MLH1 and MSH2 in unrelated south American suspected Lynch syndrome individuals. Fam Cancer 10(4):641–647. doi:10.1007/s10689-011-9461-y
Hu F, Li D, Wang Y, Yao X, Zhang W, Liang J, Lin C, Ren J, Zhu L, Wu Z, Li S, Li Y, Zhao X, Cui B, Dong X, Tian S, Zhao Y (2013) Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population. PLoS One 8(4):e60233. doi:10.1371/journal.pone.0060233
Berzina D, Irmejs A, Kalniete D, Borosenko V, Nakazawa-Miklasevica M, Ribenieks K, Trofimovics G, Gardovskis J, Miklasevics E (2012) Novel germline MLH1 and MSH2 mutations in Latvian Lynch syndrome families. Exp Oncol 34(1):49–52
Tang R, Hsiung C, Wang JY, Lai CH, Chien HT, Chiu LL, Liu CT, Chen HH, Wang HM, Chen SX, Hsieh LL (2009) Germ line MLH1 and MSH2 mutations in Taiwanese Lynch syndrome families: characterization of a founder genomic mutation in the MLH1 gene. Clin Genet 75(4):334–345. doi:10.1111/j.1399-0004.2009.01162.x
Giraldo A, Gomez A, Salguero G, Garcia H, Aristizabal F, Gutierrez O, Angel LA, Padron J, Martinez C, Martinez H, Malaver O, Florez L, Barvo R (2005) MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)—description of four novel mutations. Fam Cancer 4(4):285–290. doi:10.1007/s10689-005-4523-7
Sarroca C, Valle AD, Fresco R, Renkonen E, Peltomaki P, Lynch H (2005) Frequency of hereditary non-polyposis colorectal cancer among Uruguayan patients with colorectal cancer. Clin Genet 68(1):80–87. doi:10.1111/j.1399-0004.2005.00458.x
Rossi BM, Lopes A, Oliveira Ferreira F, Nakagawa WT, Napoli Ferreira CC, Casali Da Rocha JC, Simpson CC, Simpson AJ (2002) hMLH1 and hMSH2 gene mutation in Brazilian families with suspected hereditary nonpolyposis colorectal cancer. Ann Surg Oncol 9(6):555–561
Vaccaro CA, Bonadeo F, Roverano AV, Peltomaki P, Bala S, Renkonen E, Redal MA, Mocetti E, Mullen E, Ojea-Quintana G, Benati ML, Rivello HG, Clark MB, Lynch JF, Lynch HT (2007) Hereditary nonpolyposis colorectal cancer (Lynch syndrome) in Argentina: report from a referral hospital register. Dis Colon Rectum 50(10):1604–1611. doi:10.1007/s10350-007-9037-y
Salari K, Choudhry S, Tang H, Naqvi M, Lind D, Avila PC, Coyle NE, Ung N, Nazario S, Casal J, Torres-Palacios A, Clark S, Phong A, Gomez I, Matallana H, Perez-Stable EJ, Shriver MD, Kwok PY, Sheppard D, Rodriguez-Cintron W, Risch NJ, Burchard EG, Ziv E (2005) Genetic admixture and asthma-related phenotypes in Mexican American and Puerto Rican asthmatics. Genet Epidemiol 29(1):76–86. doi:10.1002/gepi.20079
Marcos I, Borrego S, Urioste M, Garcia-Valles C, Antinolo G (2006) Mutations in the DNA mismatch repair gene MLH1 associated with early-onset colon cancer. J Pediatr 148(6):837–839. doi:10.1016/j.jpeds.2006.01.009
Sheng JQ, Chan TL, Chan YW, Huang JS, Chen JG, Zhang MZ, Guo XL, Mu H, Chan AS, Li SR, Yuen ST, Leung SY (2006) Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer. Chin J Dig Dis 7(4):197–205. doi:10.1111/j.1443-9573.2006.00269.x
Rahner N, Friedrichs N, Wehner M, Steinke V, Aretz S, Friedl W, Buettner R, Mangold E, Propping P, Walldorf C (2007) Nine novel pathogenic germline mutations in MLH1, MSH2, MSH6 and PMS2 in families with Lynch syndrome. Acta Oncol 46(6):763–769. doi:10.1080/02841860701230217
Campbell PT, Curtin K, Ulrich CM, Samowitz WS, Bigler J, Velicer CM, Caan B, Potter JD, Slattery ML (2009) Mismatch repair polymorphisms and risk of colon cancer, tumour microsatellite instability and interactions with lifestyle factors. Gut 58(5):661–667. doi:10.1136/gut.2007.144220
Martinez-Cruzado JC, Toro-Labrador G, Viera-Vera J, Rivera-Vega MY, Startek J, Latorre-Esteves M, Roman-Colon A, Rivera-Torres R, Navarro-Millan IY, Gomez-Sanchez E, Caro-Gonzalez HY, Valencia-Rivera P (2005) Reconstructing the population history of Puerto Rico by means of mtDNA phylogeographic analysis. Am J Phys Anthropol 128(1):131–155. doi:10.1002/ajpa.20108
Patient Protection and Affordable Care Act (2010). vol 42 U.S.C. USA
Secretary’s Advisory Committee on Genetic Health and Society (2006) Coverage and reimbursment of genetic tests and services. http://oba.od.nih.gov/oba/sacghs/reports/CRreport.pdf
Pérez-Carbonell L, Ruiz-Ponte C, Guarinos C, Alenda C, Payá A, Brea A, Egoavil CM, Castillejo A, Barberá VM, Bessa X, Xicola RM, Rodríguez-Soler M, Sánchez-Fortún C, Acame N, Castellví-Bel S, Piñol V, Balaguer F, Bujanda L, De-Castro M-L, Llor X, Andreu M, Carracedo A, Soto J-L, Castells A, Jover R (2011) Comparison between universal molecular screening for Lynch syndrome and revised Bethesda guidelines in a large population-based cohort of patients with colorectal cancer. Gut. doi:10.1136/gutjnl-2011-300041
Mvundura M, Grosse SD, Hampel H, Palomaki GE (2010) The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med 12(2):93–104. doi:10.1097/GIM.0b013e3181cd666c
Ladabaum U, Wang G, Terdiman J, Blanco A, Kuppermann M, Boland CR, Ford J, Elkin E, Phillips KA (2011) Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med 155(2):69–79. doi:10.7326/0003-4819-155-2-201107190-00002
Acknowledgments
This work was partially supported by the National Institute on Minority Health Disparities Award Numbers 8U54MD 007587-03 and U54MD007587; NCI Award Numbers 5K22CA115913-03, R21CA167220-01, 5R03CA130034-02, and U54CA096297; Center for Collaborative Research in Health Disparities RCMI Award Number G12MD007600. In addition, the authors will like to thank the patients involved in the study for their treasured contribution.
Ethical standard
None of the authors have any commercial conflicts to disclose. The procedures performed during the research described here were in accordance with ethical standards of responsible human experimentation both institutional and national. Institutional Review Board of the University of Puerto Rico Medical Sciences Campus approved this study. Informed consent was obtained for patients included in the study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cruz-Correa, M., Diaz-Algorri, Y., Pérez-Mayoral, J. et al. Clinical characterization and mutation spectrum in Caribbean Hispanic families with Lynch syndrome. Familial Cancer 14, 415–425 (2015). https://doi.org/10.1007/s10689-015-9795-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-015-9795-y